(Press-News.org) PHILADELPHIA – Researchers at the University of Pennsylvania School of Medicine have determined that a well-known chemical process called acetylation has a previously unrecognized association with one of the biological processes associated with Alzheimer's disease and related disorders. The findings were published in the latest issue of Nature Communications.
Tau is one of the primary disease proteins associated with a suite of neurodegenerative diseases. Tau proteins are expressed primarily in the central nervous system where they help with the assembly and stability of microtubules, protein structures that are the backbone of the nerve-cell communication system.
"Acetylation was only detected in diseased brain tissue from patients with Alzheimer's disease or frontotemporal degeneration, suggesting it may have a role in tau transformation linked to disease onset and progression," says senior author Virginia M.-Y. Lee, PhD, director of Penn's Center for Neurodegenerative Disease Research. "This suggests that one type of acetylation is a potential target for drug discovery and biomarker development for Alzheimer's and related tauopathies."
The researchers demonstrated that tau acetylation led to a loss of one of its major functions - to promote microtubule assembly, in addition to gaining a toxic function, pathological tau aggregation. Mass spectrometry analysis identified specific acetylation sites in the tau protein sequence that overlapped with known microtubule binding sequences, so acetylation may also play a role in faulty binding of tau to microtubules.
How normal tau becomes disengaged from microtubules to form disease-related clumps remains unknown. This study shows that acetylation is most likely another chemical modification implicated in neurodegenerative disorders to be explored as a potential way to detect and fight brain disease.
According to Lee, the next steps to follow up on this discovery are to pursue basic research into the mechanisms underlying this pathological acetylation of tau and its role in neurodegeneration in Alzheimer's disease and related tauopathies. In addition, she noted that "Our highest priority will be to find ways to translate these findings into better diagnostics and therapeutics for patients with Alzheimer's disease or frontotemporal degeneration."
INFORMATION:
The first author of the study is Todd Cohen with Penn co-authors Jing Guo, David Hurtado, Linda Kwong, Ian Mills, and John Trojanowski.
This study was funded by the Association for Frontotemporal Degeneration and the National Institute on Aging.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4 billion enterprise.
Penn's School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools and among the top 10 schools for primary care. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $507.6 million awarded in the 2010 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania â€" recognized as one of the nation's top 10 hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital – the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2010, Penn Medicine provided $788 million to benefit our community.
Penn study suggests another avenue for detecting Alzheimer's disease
New biomarker for tau-related brain disorders?
2011-04-02
ELSE PRESS RELEASES FROM THIS DATE:
Pat Vitucci to Conduct Financial Seminars With KGO Radio's Len Tillem and KSFO Radio's Brian Sussman in May
2011-04-02
Pat Vitucci, a Bay Area Independent Financial Advisor, will conduct two financial seminars in May. Both seminars are complimentary and open to the public.
The first one will be in San Mateo on May 5 at the San Mateo Marriott from 4-6pm with KGO radio's Len Tillem*. The second will be at the Concord Hilton on May 12 from 1-3pm with San Francisco radio's Brian Sussman*.
Len Tillem hosts his own show from 1-2 pm every weekday on San Francisco's KGO radio and is a practicing estate planning attorney, a nice complement to Vitucci's specialty which is planning for retirement.
Brian ...
April 2011 Geosphere highlights
2011-04-02
Boulder, CO, USA - The April 2011 Geosphere includes three articles designated for the latest Geosphere theme: Exploring the Deep Sea and Beyond. Other topics include new entries to existing themes: New developments in Grenville geology; Making the Southern Margin of Laurentia; and Neogene Tectonics and Climate-Tectonic Interactions in the Southern Alaskan Orogen. Additionally, the April issue features several articles not associated with a specific theme.
Geosphere announces a new themed issue: The Exploring the Deep Sea and Beyond: Contributions to Marine Geology ...
HIPAA Ready LLC - A Top 2011 Business Changes Name to Methodical, Inc.
2011-04-02
We are proud to announce that we are changing our company name from HIPAA Ready LLC to Methodical, Inc.
Shem Isukh, President of Methodical, stated: "This is an exciting time for us with a name change that has long been overdue. As our business evolved from HIPAA Compliance, EDI, and software development to include business analysis, management consulting, and development for multiple industries outside of healthcare, it became apparent we had outgrown our original roots and name."
Sreedhar Madanapalli, Vice President of IT, also agrees the name change was needed: ...
New data show non-alcoholic fatty liver disease will reach epidemic status in the US
2011-04-02
Berlin, Germany, Saturday 02 April 2011: According to new data presented today at the International Liver CongressTM, the United States (U.S.) could soon be faced with an epidemic of Non-Alcoholic Fatty Liver Disease (NAFLD)1, one of the major contributing factors of chronic liver disease (CLD), considered as one of the major causes of morbidity and mortality worldwide. The study highlights that if the current rates of obesity and diabetes continue for another two decades, the prevalence of NAFLD in the US is expected to increase by 50% in 2030.
The study analysed pre-existing ...
Thalidomide shows efficacy as adjuvant therapy for hepatocellular carcinoma patients
2011-04-02
Berlin, Germany, Saturday 02 April 2011: Thalidomide has shown potential to be used as the first adjuvant therapy for hepatocellular carcinoma (HCC), according to data presented at the International Liver CongressTM 2011.1
A new study found thalidomide gave HCC patients who'd undergone grossly curative resection surgical removal of the cancerous part of the liver double the two-year disease free survival rate (65%) compared to placebo (33%).
However, the study did find that the two-year overall survival rate was comparable between patients treated with thalidomide ...
Data suggest liver experts should take care when prescribing novel antiviral HCV drugs
2011-04-02
Berlin, Germany, Saturday 02 April 2011: Data presented at the International Liver CongressTM highlight the fact that new novel antiviral compounds for the treatment of hepatitis C virus (HCV) must be prescribed and monitored by experts and specialists to ensure resistance is minimised.1,2,3,4,5,6
Several studies observed the rapid onset of HCV resistance in patients treated with NS3-protease, NS5b-polymerase and NS5a inhibitors. Although these direct anti-virals are effective in both treatment-naive HCV patients and those who've been previously unresponsive to current ...
SnapShotz Photobooth's Tips on "Choosing the Right Photo Booth Company" for Your Wedding
2011-04-02
Digital Photo Booths have quickly become the must-have item for weddings, birthday parties, bar and bat mitzvahs, quinceaneras, high school reunions, charities, expos and corporate events! Everyone from DJs, photographers, videographers, event coordinators, hotels and venues are all scrambling to find ways to incorporate this exciting and unique new concept into their own service offerings. With so many styles of photo booths (of varied quality) and so many companies in the market, it can be very daunting for consumers to pick the right photo booth and the right company ...
FMA Congresses; Progressive Energy and Environment Congresses. For More Info Please Call 514-787-1710
2011-04-02
Joe,
I wanted you to know that I truly appreciate the work and dedication you and your team put into the Progressive Energy and Environment congresses. So with that being said, thanks for another outstanding FMA congress. You and your team are simply amazing. Your team is always professional friendly and helpful. Once again the assembly of delegates you brought together was outstanding.
If you ever need a reference for a vendor you are looking to woo or upgrade please feel free to use me. I will be more than happy to explain to people that so far USLED has begun doing ...
Don Barnhart Comedy Show Makes Las Vegas Home To Nightly Show Starting April 12, 2100 At The Clarion Hotel & Casino
2011-03-31
While other comics are busy knocking on doors asking for work, award-winning comedian Don Barnhart is making his own opportunities and creating work for himself and fellow comedians large and small. From producing and performing comedy shows for the troops around the world to headlining the top comedy clubs across the country, Barnhart is now starring in his own show nightly in Las Vegas, NV.
The Don Barnhart Comedy Show opens at The Star Theater (Formerly The Debbie Reynolds Theater) at The Clarion Hotel (Formerly Greek Isles) April 12, 2011 providing laughter every ...
Stellar Appoints Chief Strategy Officer for Global Business
2011-03-31
Stellar, a leading call centre and business process outsourcing provider today announced that Michael Lumsden has been appointed Chief Strategy Officer of Stellar's global business.
"Michael is the ideal candidate to lead Stellar's global strategy and further enhance our offerings in the market place." said John Hollingsworth, Stellar's global CEO. "Stellar is currently undergoing major growth and Michael will work closely with each operating company CEO, together with their respective Heads of Sales and Strategy to support new initiatives and customer focussed outcomes," ...
LAST 30 PRESS RELEASES:
Twelve questions to ask your doctor for better brain health in the new year
Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes
Study identifies genetic cause for yellow nail syndrome
New drug to prevent migraine may start working right away
Good news for people with MS: COVID-19 infection not tied to worsening symptoms
Department of Energy announces $179 million for Microelectronics Science Research Centers
Human-related activities continue to threaten global climate and productivity
Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued
Unraveling the power and influence of language
Gene editing tool reduces Alzheimer’s plaque precursor in mice
TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies
Twisted Edison: Bright, elliptically polarized incandescent light
Structural cell protein also directly regulates gene transcription
Breaking boundaries: Researchers isolate quantum coherence in classical light systems
Brain map clarifies neuronal connectivity behind motor function
Researchers find compromised indoor air in homes following Marshall Fire
Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality
Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology
'Glass fences' hinder Japanese female faculty in international research, study finds
Vector winds forecast by numerical weather prediction models still in need of optimization
New research identifies key cellular mechanism driving Alzheimer’s disease
Trends in buprenorphine dispensing among adolescents and young adults in the US
Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility
Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity
Association of state cannabis legalization with cannabis use disorder and cannabis poisoning
Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders
Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals
Unlocking the mysteries of the human gut
High-quality nanodiamonds for bioimaging and quantum sensing applications
New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia
[Press-News.org] Penn study suggests another avenue for detecting Alzheimer's diseaseNew biomarker for tau-related brain disorders?